These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9274851)

  • 1. Effect of oral adsorbent on the progression of diabetic nephropathy.
    Okada K; Shibahara H; Takahashi S
    Nephron; 1997; 76(4):489-90. PubMed ID: 9274851
    [No Abstract]   [Full Text] [Related]  

  • 2. Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats.
    Cai Y; Chen J; Jiang J; Cao W; He L
    J Ethnopharmacol; 2010 Aug; 131(1):88-94. PubMed ID: 20547220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats.
    Sun H; Ge N; Shao M; Cheng X; Li Y; Li S; Shen J
    Diabetes Res Clin Pract; 2013 Apr; 100(1):85-95. PubMed ID: 23384615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy.
    Kumar GS; Kulkarni A; Khurana A; Kaur J; Tikoo K
    Chem Biol Interact; 2014 Nov; 223():125-33. PubMed ID: 25301743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
    Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
    Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model.
    Elmas O; Erbas O; Yigitturk G
    Biomed Pharmacother; 2016 Oct; 83():392-396. PubMed ID: 27424320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between insulin resistance and uremic toxins in the gastrointestinal tract.
    Okada K; Takahashi Y; Okawa E; Onishi Y; Hagi C; Aoki K; Shibahara H; Higuchi T; Nagura Y; Kanmatsuse K; Takahashi S
    Nephron; 2001 Aug; 88(4):384-6. PubMed ID: 11474237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
    Mulay SR; Gaikwad AB; Tikoo K
    Chem Biol Interact; 2010 Apr; 185(2):137-42. PubMed ID: 20223228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of nephron-protective effects of enalapril and GLP analogues (exenatide) in diabetic nephropathy.
    Çavusoglu T; Erbas O; Karadeniz T; Akdemir O; Acikgoz E; Karadeniz M; Tuglu MI; Ates U
    Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):327-33. PubMed ID: 24941431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral adsorbent AST-120 ameliorates interstitial fibrosis and transforming growth factor-beta(1) expression in spontaneously diabetic (OLETF) rats.
    Aoyama I; Shimokata K; Niwa T
    Am J Nephrol; 2000; 20(3):232-41. PubMed ID: 10878408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats.
    Aoyama I; Shimokata K; Niwa T
    Nephron; 2002; 92(3):635-51. PubMed ID: 12372949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat.
    Wittmann S; Daniel C; Stief A; Vogelbacher R; Amann K; Hugo C
    Transplantation; 2009 May; 87(9):1290-9. PubMed ID: 19424027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
    Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
    J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
    Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
    Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH
    Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.